Literature DB >> 1136570

Effects of intravenously administered isoxsuprine in patients with Raynaud's phenomenon.

H Wesseling, A A Wouda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1136570

Source DB:  PubMed          Journal:  Vasa        ISSN： 0301-1526            Impact factor:   1.961


× No keyword cloud information.
  2 in total

1.  Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.

Authors:  H Wesseling; A den Heeten; A A Wouda
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening.

Authors:  Jeff W Hill; Jeffrey F Thompson; Mark B Carter; Bruce S Edwards; Larry A Sklar; Gary A Rosenberg
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.